MDLA.JK PT Medela Potentia Tbk
- Market cap
- IDR 2.65T
- P/E
- 6.5x
- P/B
- 0.87x
- ROE
- 14.4%
- Dividend yield
- 5.19%
- Fundamental score
- 2.9/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is MDLA.JK undervalued?
Graham numberMDLA.JK trades 50.0% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PT Medela Potentia Tbk fundamental analysis
14 of 22 checks passedROE 1/2
Moderate return on equity (14.4%), between 10% and 20%.
ROA 1/1
Return on assets (6.7%) is above the industry median (1.9%).
Profit Consistency 2/2
Profitable for 5 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-19.8%) is below the industry median (2.3%).
Revenue Growth 1/2
Revenue grew 8.4% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (2.3%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 1/1
EBIT is 74.6x against interest expense, well covered.
PE vs Market 1/1
PE (6.5x) is below the market median (12.0x).
PE vs Industry 1/1
PE (6.5x) is below the industry median (12.0x).
PBV 1/1
Price to book (0.9x) is below the industry median (1.2x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 5.7, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (5.1%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 35.0%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
PT Medela Potentia Tbk stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PT Medela Potentia Tbk
PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its pr…
Full company profilePT Medela Potentia Tbk financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PT Medela Potentia Tbk annual financial statements (IDR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 11.6T | 11.7T | 13.1T | 14.6T | 14.9T | 16.3T |
| Gross Profit | 1.08T | 1.10T | 1.23T | 1.36T | 1.44T | 1.44T |
| Operating Income | 425B | 406B | 408B | 466B | 497B | 481B |
| EBITDA | 509B | 498B | 502B | 563B | 613B | 566B |
| Net Income | 325B | 312B | 303B | 345B | 392B | 442B |
| EPS | 23 | 22 | 22 | 35 | 28 | 32 |
| Balance Sheet | ||||||
| Total Assets | 3.79T | 4.42T | 4.70T | 5.73T | 6.58T | 6.61T |
| Total Liabilities | 2.06T | 2.71T | 2.75T | 3.52T | 3.48T | 3.45T |
| Shareholders' Equity | 1.72T | 1.64T | 1.88T | 2.14T | 3.04T | 3.08T |
| Cash & Short-term Investments | 769B | 840B | 270B | 380B | 1.00T | 559B |
| Total Debt | 151B | 376B | 182B | 231B | 80.7B | 72.1B |
| Cash Flow | ||||||
| Operating Cash Flow | 484B | 288B | -167B | 198B | 522B | -458B |
| Capital Expenditure | 55.5B | 52.9B | 75.5B | 47.4B | 219B | 53.7B |
| Free Cash Flow | 428B | 235B | -242B | 151B | 302B | -512B |
| Ratios | ||||||
| ROE | 18.9% | 19.0% | 16.1% | 16.1% | 12.9% | 14.4% |
| ROA | 8.6% | 7.1% | 6.5% | 6.0% | 6.0% | 6.7% |
| Net Profit Margin | 2.8% | 2.7% | 2.3% | 2.4% | 2.6% | 2.7% |
| Debt to Equity | 0.09x | 0.23x | 0.10x | 0.11x | 0.03x | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
PT Medela Potentia Tbk dividends
- Dividend yield
- 5.19%
- Forward dividend
- 12.60 IDR
- Payout ratio
- 35.0%
- Ex-dividend date
- May 25, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | IDR 137B | 9.80 | 35.0% |
| 2024 | IDR 115B | 12 | 33.3% |
| 2023 | IDR 60.0B | 4.28 | 19.8% |
| 2022 | IDR 364B | 26 | 116.7% |
| 2021 | IDR 12.0B | 0.86 | 3.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns PT Medela Potentia Tbk
- Insiders 90.45%
- Institutions 6.88%
- Public & others 2.68%
- Shares outstanding 14.0B
- Free float 2.45B
PT Medela Potentia Tbk company profile
- Company name
- PT Medela Potentia Tbk
- Ticker
- MDLA.JK
- Exchange
- Jakarta Exchange
- Sector
- Healthcare
- Industry
- Medical Distribution
- Employees
- 2,205
- Fiscal year end
- December
- Address
- Jl. RS. Fatmawati Kav. 33, Jakarta Selatan, Indonesia, 12430
- Phone
- 62 21 7486 4210
- Website
- medela-potentia.com
About PT Medela Potentia Tbk
PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its products to retailers, end consumers, and patients. PT Medela Potentia Tbk was founded in 2011 and is headquartered in Jakarta Selatan, Indonesia.
PT Medela Potentia Tbk management
3- Ms. . JuliwatyPresident Director
- Mr. Tresno DhiwangkaraHead of the Internal Audit Unit
- Mr. Wimala WidjajaCorporate Secretary & Director · born 1955